Paragraph IV Notice. If either Party receives a notice under 21 U.S.C. §355(b)(2)(A)(iv) or 355(j)(2)(A)(vii)(IV) concerning any MannKind Patent, Joint Patent or United Therapeutics Patent, then it shall provide a copy of such notice to the other Party within two Business Days after its receipt thereof. Patent infringement litigation based on such a notice concerning a MannKind Patent, Joint Patent or United Therapeutics Patent shall be brought and controlled as provided in Section 9.3(b) or 9.3(c) as applicable.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Mannkind Corp), License and Collaboration Agreement (UNITED THERAPEUTICS Corp), License and Collaboration Agreement (Mannkind Corp)
Paragraph IV Notice. If either Party receives a notice under 21 U.S.C. §355(b)(2)(A)(iv) or 355(j)(2)(A)(vii)(IV) (or any foreign equivalent) concerning any MannKind PEM Patent, Joint Patent or United Therapeutics PAC Patent, then it shall provide a copy of such notice to the other Party within two Business Days after its receipt thereof. Patent infringement litigation based on such a notice concerning a MannKind PEM Patent, Joint Patent or United Therapeutics PAC Patent shall be brought and controlled as provided in Section 9.3(b), 9.3(c) or 9.3(c) 9.3(d), as applicable.
Appears in 1 contract
Samples: License and Collaboration Agreement (Planet Alpha Corp.)
